4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-16-087951
CIK 0001572552operating
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:30 PM ET
Size
8.6 KB
Accession
0001140361-16-087951
Insider Transaction Report
Form 4
Spink Katharine E.
Vice President & COO
Transactions
- Exercise/Conversion
Options to Purchase Common Stock
2016-11-23+2,500→ 195,000 totalExercise: $2.34From: 2013-03-10Exp: 2020-03-09→ Common Stock (2,500 underlying) - Sale
Common Stock
2016-11-23$5.41/sh−2,500$13,525→ 0 total - Exercise/Conversion
Common Stock
2016-11-23$2.34/sh+2,500$5,850→ 2,500 total
Footnotes (3)
- [F1]The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
- [F2]Excludes 7,658 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.45, inclusive. The reporting person undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 4:30 PM ET
- Size
- 8.6 KB